RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299 | -32.4% | 35,551 | +1.0% | 0.00% | -100.0% |
| Q2 2023 | $442 | -52.0% | 35,193 | -37.1% | 0.00% | 0.0% |
| Q1 2023 | $921 | -9.8% | 55,916 | -18.2% | 0.00% | 0.0% |
| Q4 2022 | $1,021 | -99.9% | 68,347 | -0.0% | 0.00% | -50.0% |
| Q3 2022 | $1,529,000 | +44.0% | 68,366 | +7.8% | 0.00% | +100.0% |
| Q2 2022 | $1,062,000 | -32.1% | 63,393 | +21.2% | 0.00% | -50.0% |
| Q1 2022 | $1,565,000 | +16.6% | 52,304 | +19.7% | 0.00% | +100.0% |
| Q4 2021 | $1,342,000 | -1.5% | 43,692 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $1,362,000 | -26.4% | 43,200 | -14.6% | 0.00% | -50.0% |
| Q2 2021 | $1,851,000 | +43.6% | 50,593 | +35.6% | 0.00% | +100.0% |
| Q1 2021 | $1,289,000 | +6.2% | 37,300 | +27.7% | 0.00% | 0.0% |
| Q4 2020 | $1,214,000 | -2.4% | 29,200 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $1,244,000 | – | 29,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |